Revolution Medicines (MEX:RVMD) 3-1 Month Momentum %: N/A% (As of Aug. 18, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:RVMD Revolution Medicines Inc MEX:RVMD
11 GF Score
Price MXN3,465.28
! 3 Warning Signs
View Full Analysis

What is Revolution Medicines 3-1 Month Momentum %?

Revolution Medicines MEX:RVMD 11 3-1 Month Momentum % is N/A% as of Aug. 18, 2026. GuruFocus rates MEX:RVMD with a GF Score™ of 11/100. The stock has 3 warning signs investors should review. Among 1,387 Biotechnology companies, Revolution Medicines ranks better than 90.05% on this metric.

3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-08-18), Revolution Medicines's 3-1 Month Momentum % is N/A%.

The industry rank for Revolution Medicines's 3-1 Month Momentum % or its related term are showing as below:

MEX:RVMD's 3-1 Month Momentum % is not ranked *
in the Biotechnology industry.
Industry Median: -7.61
* Ranked among companies with meaningful 3-1 Month Momentum % only.

Revolution Medicines  (MEX:RVMD) 3-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.

Revolution Medicines 3-1 Month Momentum % Related Terms

MEX:RVMD
11GF Score
Revolution Medicines Inc MEX:RVMD
3-1 Month Momentum % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Revolution Medicines  (MEX:RVMD) 3-1 Month Momentum % Calculation

3-1 Month Momentum % is calculated as following:

3-1 Month Momentum %=( Price 1-month ago / Price 3-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 3-1 Month Momentum % →
What does a 3-1 Month Momentum % of N/A% mean?
Revolution Medicines (MEX:RVMD) has a 3-1 Month Momentum % of N/A% as of Aug. 18, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Revolution Medicines and its competitors. According to the industry distribution chart, Revolution Medicines ranks #138 out of 1387 companies in the Biotechnology industry, placing it in the top 9.9%.
Is Revolution Medicines' 3-1 Month Momentum % too high?
Revolution Medicines' current 3-1 Month Momentum % is N/A%. Based on the distribution chart, Revolution Medicines ranks #138 out of 1387 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Revolution Medicines has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Revolution Medicines' 3-1 Month Momentum % compare to ALNY and ONC?
According to the Biotechnology industry distribution chart, Revolution Medicines ranks #138 out of 1387 companies for 3-1 Month Momentum %. This places Revolution Medicines in the top 10% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Biotechnology company?
A good 3-1 Month Momentum % depends on the Biotechnology industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Revolution Medicines and its competitors. Revolution Medicines's current 3-1 Month Momentum % is N/A%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Revolution Medicines stock overvalued right now?
Revolution Medicines (MEX:RVMD) has a current 3-1 Month Momentum % of N/A%. The current 3-1 Month Momentum % is N/A%. Revolution Medicines' overall GF Score™ is 11/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Revolution Medicines (MEX:RVMD), the current 3-1 Month Momentum % is N/A% as of Aug. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Revolution Medicines Business Description

Address 700 Saginaw Drive, Redwood City, CA, USA, 94063
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.
11GF Score

Get the complete analysis for MEX:RVMD

3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN3,465.28
Price